Identification of Factors Contributing to Pathogenic Variability Among Lassa Virus Strains Using the Guinea Pig Model and Reverse Genetics - Top-Institutions - MDSpire

Identification of Factors Contributing to Pathogenic Variability Among Lassa Virus Strains Using the Guinea Pig Model and Reverse Genetics

  • By

  • Satoshi Taniguchi

  • Takeshi Saito

  • Ruchi Paroha

  • Cheng Huang

  • Slobodan Paessler

  • Junki Maruyama

  • June 21, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories
    National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories

    Hamilton, Montana

    Key Differentiators

    • Infectious Diseases
    • Virology
    • Biosafety Level 4 Research

  • #2

    Bernhard Nocht Institute for Tropical Medicine
    Bernhard Nocht Institute for Tropical Medicine

    Hamburg, Germany

    Key Differentiators

    • Tropical Medicine
    • Virology
    • Emerging Infectious Diseases

  • #3

    University of Lagos, College of Medicine
    University of Lagos, College of Medicine

    Lagos, Nigeria

    Key Differentiators

    • Infectious Diseases
    • Virology
    • Public Health

  • #4

    Centers for Disease Control and Prevention (CDC), Viral Special Pathogens Branch
    Centers for Disease Control and Prevention (CDC), Viral Special Pathogens Branch

    Atlanta, Georgia

    Key Differentiators

    • Virology
    • Epidemiology
    • Biosafety Level 4 Research

Original Source(s)

Identification of Factors Contributing to Pathogenic Variability Among Lassa Virus Strains Using the Guinea Pig Model and Reverse Genetics

  • by Satoshi Taniguchi, Takeshi Saito, Ruchi Paroha, Cheng Huang, Slobodan Paessler, Junki Maruyama

  • June 21, 2025

Related Content

Medical Oddities: Friends, Family… and Faster Aging?

From gut gas trackers to bat vaccines, relationships and aging, GLP-1 hair shifts, and bug-based delivery—medicine keeps getting creative.

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

Matrix Stiffness Regulates Gingival Immunity

3D hydrogel and explant models link tissue mechanics to fibroblast signaling and immune cell differentiation.